NOI - Olink Explore HT Proteomic Analysis for Sepsis Biomarker Study

Combined Synopsis/SolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in BETHESDA, MD
  • Industry: Testing Laboratories and Services

Contract Details

Notice ID
75N98026Q00280
Opportunity Type
Combined Synopsis/Solicitation
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Posted Date
Wednesday, April 29, 2026
Response Deadline
Wednesday, May 13, 2026
PSC Code
Q301
Set-Aside
No Set Aside
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement involves analysis of plasma samples from a non-human primate septic shock model to support research on inflammatory biomarkers and therapeutic response. The contractor shall provide sample processing, assay execution, quality control, and delivery of normalized, analysis-ready datasets. This notice is issued as a Notice of Intent for a non-competitive award; however, interested parties may submit capability statements demonstrating their ability to meet the Governments requirement.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for testing laboratories and services with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.